Kratom: A New Product in an Expanding Substance Abuse Market

Hamid R Tavakoli; Andrew C Buchholz; Ishraq K Kabir; Arjamon Deb; John N Gayk

Kratom: A New Product in an Expanding Substance Abuse Market

Fed Pract. 2016 Nov;33(11):32-36.

Authors

Hamid R Tavakoli¹, Andrew C Buchholz¹, Ishraq K Kabir¹, Arjamon Deb¹, John N Gayk¹

Affiliation

¹ is the head of the Psychiatry Consult Service and Research for the department of psychiatry and is a psychiatry resident at Naval Medical Center Portsmouth in Virginia. is a surgical intern at Eastern Virginia Medical School in Norfolk. is an intern at the University of Pittsburgh Medical Center in Pennsylvania. is an intern at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina. Dr. Tavakoli also is an associate professor at Uniformed Services University of Health Sciences in Bethesda, Maryland, and Eastern Virginia Medical School.

PMID: 30766148
PMCID: PMC6373705

Abstract

Kratom, a drug that produces similar adverse effects like those produced by opioids in patients who have overdosed or are going through withdrawal, has grown in popularity and availability.